Womens Imaging: Page 367

Bigger is better for breast tumor resection margins
By Cynthia E. Keen
Women diagnosed with ductal carcinoma in situ who have a lumpectomy face the lowest risk of cancer recurrence when enough breast tissue is resected to have a pathologically confirmed wide negative margin, according to an article published online March 22 in the Journal of the National Cancer Institute.
March 22, 2012
Studies explore how density, screening affect breast cancer
By Kate Madden Yee
At this week's European Breast Cancer Conference in Vienna, researchers discussed the link between breast density and cancer recurrence, whether early screening reduces mortality, and when MRI should be added to breast screening.
March 22, 2012
AuntMinnie.com Women's Imaging Insider
By Kate Madden Yee
March 21, 2012
Lower radiation dose could turn DBT into breast screening tool
By Kate Madden Yee
The potential use of digital breast tomosynthesis (DBT) for screening mammography has been in question due to the modality's higher radiation dose. But a new study in the April Radiology offers several scenarios in which DBT dose could ultimately be lower than that of two-view full-field digital mammography.
March 21, 2012
Racial disparity contributes to breast cancer mortality
By AuntMinnie.com staff writers
Racial disparity affects breast cancer care, with nearly five black women dying needlessly per day from breast cancer in the U.S., according to a study published on Wednesday in Cancer Epidemiology as well as in the Avon Foundation Breast Cancer Forum.
March 20, 2012
Matakina gets Canadian approval for Volpara
By AuntMinnie.com staff writers
Matakina International said it has received a medical device license by the Medical Devices Bureau of Health Canada to sell and market its Volpara breast imaging software in the country.
March 20, 2012
SonoCine names Medipattern as distributor in Canada
By AuntMinnie.com staff writers
Automated whole-breast ultrasound technology developer SonoCine has signed computer-aided detection developer Medipattern as its exclusive Canadian distributor.
March 19, 2012
PET/CT predicts survival of patients with hepatic metastases
By Wayne Forrest
FDG-PET/CT is useful for predicting the survival of breast cancer patients with hepatic metastases after treatment with selective internal radiation therapy (SIRT), according to a study published in the March issue of the Journal of Nuclear Medicine.
March 18, 2012
2012 03 16 14 11 22 443 Pet Ct Liver Metastases Thumb
The Practice of Ultrasound: Part 4 -- Female pelvic ultrasound
By Dr. Jason Birnholz
AuntMinnie.com presents the fourth in a series of columns on the practice of ultrasound from Dr. Jason Birnholz, one of the pioneers of this modality. In this installment, Dr. Birnholz discusses the history and strengths and weaknesses of ob/gyn ultrasound, which is often inappropriately utilized.
March 15, 2012
2011 09 07 15 05 28 76 Birnholz Jason 70
iCAD launches postmarket IORT study
By AuntMinnie.com staff writers
iCAD has launched a postmarketing study to assess the safety and efficacy of the company's Xoft Axxent eBx system when used for single-fraction intraoperative radiation therapy (IORT) at the time of lumpectomy for early-stage breast cancer.
March 14, 2012
Fischer named U.S. distributor for Giotto FFDM system
By AuntMinnie.com staff writers
Italian women's imaging vendor Internazional Medico Scientifica (IMS) has named Fischer Medical Technologies as the exclusive U.S. distributor for the Giotto full-field digital mammography (FFDM) system.
March 12, 2012
NCBC: Breast density legislation cause for celebration?
By Kate Madden Yee
The issue of dense breast tissue has long been a contentious one. As proponents of density notification pursue a legislative agenda, breast care centers must ensure they don't alienate women by opposing such efforts, according to a talk at the National Consortium of Breast Centers (NCBC) meeting in Las Vegas.
March 12, 2012
Previous Page
Page 367 of 692
Next Page